乾貨諮訊

Smegglutide Breakthrough in Fatty Liver Treatme...

MASH: The Silent "Chronic Fire" of the Liver, Urgently Needing Effective Treatment. Metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH) is a progressive form of fatty liver disease. Its pathological...

Safety Guidelines for the Use of Tesipatide in ...

The prevalence of diabetes in people over 60 years of age exceeds 30% , with over 40% of these patients also obese . Elderly patients face a triple challenge: ●...

Can Leboresen be taken long-term? — A professio...

 A 12-month clinical study confirmed that after continuous use of Leboresen in 1,006 patients with chronic insomnia, the efficacy was stable and there was no significant drug resistance. However, 0.3%...

Teijin Gout (Febuxostat) – A Uric Acid-Lowering...

After a beer, the joints ache like they're being stabbed with needles—this is a nightmare experienced by countless gout patients in the dead of night . Febuxostat, developed by Teijin...

曲格列汀琥珀酸鹽片搭配健康飲食，減重更有效率

每週只需一顆的藥片，配合科學的飲食策略，讓第二型糖尿病患者在血糖平穩下降的同時，見證頑固脂肪的悄悄消失。張女士曾陷入典型的糖尿病困境：使用胰島素後血糖下降，體重卻一年飆升5公斤。在腰圍成長的同時，空腹血糖仍波動在8-10mmol/L之間－這是全球超過80%使用傳統降血糖藥患者的真實寫照。但當她將胰島素更換為曲格列汀琥珀酸鹽片，並調整飲食結構後，奇蹟發生了： 4個月內減重6公斤，腰圍縮小7厘米，空腹血糖穩定在6.0-6.8mmol/L範圍。更關鍵的是，她無需忍受飢餓煎熬，晚餐仍可安心吃半碗米飯。

高尿酸血症七大危害與帝人痛風（非布司他）的臨床地位

高尿酸血症已躍升為繼“三高”後的“第四高”，在中國患病率超13%，但公眾對其認知仍多停留在“痛風”層面。事實上，長期高尿酸是全身多器官損害的「隱形推手」 。本文結合最新指引與臨床研究，深入解析高尿酸血症的系統性危害，並剖析原研藥帝人痛風（非布司他）在治療中的核心地位與科學應用策略。